The splicing factor QKI inhibits metastasis by modulating alternative splicing of E-Syt2 in papillary thyroid

Mengya Zhao1, Yu Jin2, Zhongyi Yan3

  • 1Department of Head and Neck Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University & The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center Nanjing, Nanjing Medical University, Nanjing, China; Wuxi People's Hospital, Wuxi Medical Center Nanjing & Department of Immunology, School of Basic Medical Science & Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China; The Affiliated Huai'an No. 1 People's Hospital, Nanjing Medical University, Nanjing, China.

Cancer Letters
|September 21, 2024
PubMed

Insights

Quaking protein (QKI) downregulation promotes papillary thyroid carcinoma (PTC) growth and metastasis by altering splicing. Targeting QKI or its related splicing events may offer new therapeutic strategies for PTC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Alternative splicing (AS) is implicated in cancer development and progression.
  • Aberrant AS events contributing to papillary thyroid carcinoma (PTC) metastasis are not well understood.

Purpose of the Study:

  • To investigate the role of the splicing factor quaking protein (QKI) in PTC metastasis.
  • To elucidate the molecular mechanisms linking QKI to PTC progression.

Main Methods:

  • Analysis of QKI expression in PTC patient samples and correlation with survival.
  • In vitro and in vivo functional studies to assess the impact of QKI on PTC cell behavior.
  • Mechanistic investigations involving alternative splicing of extended synaptotagmin 2 (E-Syt2) and interactions with long non-coding RNA eosinophil granule ontogeny transcript (EGOT).

Main Results:

  • QKI was significantly downregulated in PTC and associated with poor patient outcomes.
  • Reduced QKI expression enhanced PTC cell growth and metastasis.
  • Low QKI levels induced exon 14 retention of E-Syt2, generating an oncogenic E-Syt2 long isoform (E-Syt2L).
  • Overexpressed EGOT suppressed QKI activity by inhibiting USP25-mediated deubiquitination and degradation.

Conclusions:

  • QKI functions as a tumor suppressor in PTC metastasis.
  • The QKI/E-Syt2 splicing axis represents a novel mechanism driving PTC metastasis.
  • Targeting aberrant splicing events, particularly those involving QKI, presents a potential therapeutic avenue for PTC.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.2K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
7.0K
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K